Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06192017
Status:
RECRUITING
Last Update Posted:
2024-01-26
First Post:
2023-12-20
Brief Title:
Development of a Molecular Diagnostic Tool for Endometrial Cancer
Sponsor:
MiMARK Diagnostics SL
Organization:
MiMARK Diagnostics SL
Study Overview
Official Title:
Development of a Molecular Diagnostic Tool for Endometrial Cancer
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
WomEC is an in vitro diagnostic test for Endometrial Cancer EC based on the detection of the expression level of a combination of 5 proteins in the soluble fraction of a pipelle biopsy specimen The aim of the study consists in validating WomECs ELISA test creating and freezing an algorithm to rule out EC in post-menopausal women with abnormal uterine bleeding AUB
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None